MNCHIP is a provider of microfluidic devices for in-vitro diagnostics (IVD). Founded in 2010 in China, the company is dedicated to simplifying the complex process of biochemical testing and reducing medical expenses through the application of advanced microfluidic technology. MNCHIP's commitment to improving human and animal health is evidenced by their two series of medical and veterinary chemistry analyzers—Celercare® and Pointcare®. These products have received certifications including CFDA, CE, and ISO13485, meeting the registration requirements of various countries.
The company secured a CNY20.00M Series B investment on 28 July 2015, with Legend Capital as the investor. MNCHIP's presence in the Biotechnology, Health Care, and Medical Devices industries showcases its potential in the healthcare sector and its alignment with the current market trends.